These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

873 related articles for article (PubMed ID: 29266437)

  • 1. Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision.
    Hsieh JJ; Le V; Cao D; Cheng EH; Creighton CJ
    J Pathol; 2018 Apr; 244(5):525-537. PubMed ID: 29266437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clear cell carcinomas of the ovary and kidney: clarity through genomics.
    Ji JX; Wang YK; Cochrane DR; Huntsman DG
    J Pathol; 2018 Apr; 244(5):550-564. PubMed ID: 29344971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses.
    McAlpine J; Leon-Castillo A; Bosse T
    J Pathol; 2018 Apr; 244(5):538-549. PubMed ID: 29344951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular pathology of cancer: from pan-genomics to post-genomics.
    Huntsman DG; Ladanyi M
    J Pathol; 2018 Apr; 244(5):509-511. PubMed ID: 29436707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genomics of renal cell carcinoma and its role in renal mass biopsy.
    Salami SS; George AK; Udager AM
    Curr Opin Urol; 2018 Jul; 28(4):383-391. PubMed ID: 29708949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omics sciences and precision medicine in kidney cancer.
    Dhuli K; Micheletti C; Medori MC; Maltese PE; Tanzi B; Tezzele S; Mareso C; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Beccari T; Ceccarini MR; Stuppia L; Gatta V; Cristoni S; Cecchin S; Marceddu G; Bertelli M
    Clin Ter; 2023; 174(Suppl 2(6)):46-54. PubMed ID: 37994748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic pathways involved in carcinogenesis of clear cell renal cell carcinoma: genomics towards personalized medicine.
    Audenet F; Yates DR; Cancel-Tassin G; Cussenot O; RouprĂȘt M
    BJU Int; 2012 Jun; 109(12):1864-70. PubMed ID: 22035299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging significance of secondary germline testing in cancer genomics.
    Mandelker D; Zhang L
    J Pathol; 2018 Apr; 244(5):610-615. PubMed ID: 29293272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma.
    Wu P; Liu JL; Pei SM; Wu CP; Yang K; Wang SP; Wu S
    BMC Cancer; 2018 Mar; 18(1):287. PubMed ID: 29534679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel insights into the disease dynamics of B-cell lymphomas in the Genomics Era.
    Chan FC; Lim E; Kridel R; Steidl C
    J Pathol; 2018 Apr; 244(5):598-609. PubMed ID: 29359812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Established, emerging and elusive molecular targets in the treatment of lung cancer.
    Gallant JN; Lovly CM
    J Pathol; 2018 Apr; 244(5):565-577. PubMed ID: 29344953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards individualized therapy for metastatic renal cell carcinoma.
    Kotecha RR; Motzer RJ; Voss MH
    Nat Rev Clin Oncol; 2019 Oct; 16(10):621-633. PubMed ID: 30992569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complexity of the genomic landscape of renal cell carcinoma: Implications for targeted therapy and precision immuno-oncology.
    Sanfrancesco JM; Cheng L
    Crit Rev Oncol Hematol; 2017 Nov; 119():23-28. PubMed ID: 29065981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoural heterogeneity may hinder precision medicine strategies in patients with clear cell renal cell carcinoma.
    Raspollini MR; Montagnani I; Montironi R; Castiglione F; Martignoni G; Cheng L; Lopez-Beltran A
    J Clin Pathol; 2018 May; 71(5):467-471. PubMed ID: 29317515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papillary Renal Cell Carcinoma (PRCC): An Update.
    Akhtar M; Al-Bozom IA; Al Hussain T
    Adv Anat Pathol; 2019 Mar; 26(2):124-132. PubMed ID: 30507616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and Metabolic Subtypes in Sporadic and Inherited Clear Cell Renal Cell Carcinoma.
    Czyzyk-Krzeska MF; Landero Figueroa JA; Gulati S; Cunningham JT; Meller J; ShamsaeI B; Vemuri B; Plas DR
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33803184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary Renal Cell Carcinoma Syndromes: Clinical, Pathologic, and Genetic Features.
    Adeniran AJ; Shuch B; Humphrey PA
    Am J Surg Pathol; 2015 Dec; 39(12):e1-e18. PubMed ID: 26559379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal Cell Tumors: Understanding Their Molecular Pathological Epidemiology and the 2016 WHO Classification.
    Inamura K
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29053609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
    Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precision medicine from the renal cancer genome.
    Riazalhosseini Y; Lathrop M
    Nat Rev Nephrol; 2016 Nov; 12(11):655-666. PubMed ID: 27694978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.